GlassScriptPhysician profile
Clay D Miller
NPI 1942288410
$1,939.14
in general payments reported to CMS, 2019-2025
15 companies · $298 in 2025
The $298 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $744 · 2020: $350 · 2021: $19.83 · 2022: $43.10 · 2023: $345 · 2024: $139 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $782.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $426.13 | 2019-2022 | |
| Amgen INC. | $382.53 | 2019-2024 | Evenity |
| Pacira Therapeutics, INC. | $268.76 | 2019-2021 | |
| Stryker Corporation | $242.84 | 2025 | Mako |
| Abbott Laboratories | $172.81 | 2023-2024 | Octrode, Lamitrode Tripole |
| Lilly USA, LLC | $92.11 | 2019 | |
| Medacta USA, INC. | $88.35 | 2023 | Amistem |
| Bioventus LLC | $75.88 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Medline Industries LP | $53.78 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $40.04 | 2023 | Zilretta, Iovera, Exparel |
| Si-Bone, INC. | $31.80 | 2019 | |
| Depuy Synthes Sales INC. | $20.81 | 2019 | |
| Zimmer Biomet Holdings, INC. | $19.53 | 2025 | |
| Spr Therapeutics, INC | $12.55 | 2025 | Sprint Pns System |
| Smith+Nephew, INC. | $11.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clay Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.